Loss Widens at Cell Therapeutics

Cell Therapeutics (CTIC) suffered a net loss of $51.0 million (6 cents per share) in the first quarter of 2011, compared with a net loss of $44.2 million (7 cents per share) in the year-ago quarter. The lower loss per share in the reported quarter was due to a higher share count (878 million versus [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.